Verticillium wilt (caused by Verticillium dahliae), a soilborne disease, often causes significant reductions of yield in eggplant (Solanum melongena L.) production where crop rotation is limited. Rootstock replacement through grafting is considered an effective method to control this disease. This 2-year study investigated the eggplant yield, resistance to verticillium wilt, and allelochemicals in root exudates of eggplant grafted onto a tomato rootstock. Both disease incidence and disease severity on grafted eggplant were markedly lower than those of nongrafted eggplants. Fifteen days after V. dahliae inoculation, grafted eggplants did not exhibit any infection, whereas the disease incidence and disease severity index of the nongrafted eggplants were 68.3% and 37.8% in 2006 and 66.7% and 36.3% in 2007, respectively. Twenty-five days after inoculation, disease incidences on grafted eggplants were only 8.1% and 9.5% in 2006 and 2007, respectively, but those of the nongrafted eggplants increased to 100%. As a result, early yield, total yield, and average fruit weight were significantly increased by grafting when inoculated with V. dahliae in 2006 and 2007. Mycelium growth of V. dahliae was inhibited by the root exudates of grafted eggplants. In contrast, the root exudates of nongrafted eggplants enhanced the mycelium growth. The gas chromatography–mass spectrometry analysis revealed that the composition in the root exudates released by grafted eggplants differed not only from the nongrafted eggplants, but also from the tomato rootstock plants. Ten chemical classes were isolated and identified in root exudates of grafted eggplants. Carbazoles, amines, azulene, and fluorene were only detected in the grafted eggplants. The relative contents of ester compounds were the highest in the root exudates from the grafted eggplant followed by derivatives of benzene, whereas the relative contents of benzene derivatives were much higher than that of the ester compounds in the root exudates from the nongrafted eggplant and tomato rootstock.

Nanotechnology provides synthetic carriers for cancer drug delivery that protect cargos from degradation, control drug release and increase local accumulation at tumors. However, these non-natural vehicles display poor tumor targeting and potential toxicity and are eliminated by the immune system. Recently, biomimetic nanocarriers have been widely developed based on the concept of 'mimicking nature.' Among them, cell-derived biomimetic vehicles have become the focus of bionics research because of their multiple natural functions, such as low immunogenicity, long circulation time and targeting ability. Cell membrane-coated carriers and extracellular vesicles are two widely used cell-based biomimetic materials. Here, this review summarizes the latest progress in the application of these two biomimetic carriers in targeted cancer therapy. Their properties and performance are compared, and their future challenges and development prospects are discussed.

No abstract

Eleven new diglycosides, erycibosides A-K (1-11), four new chlorogenic acid derivatives (14-17), and a new bis-coumarin (18), together with 21 known compounds, have been isolated from an EtOH extract of the roots and stems of Erycibe hainanesis. Their structures were elucidated by means of spectroscopic methods and chemical evidence. Inhibitory activities of some of the compounds on d-galactosamine-induced cytotoxicity in WB-F344 rat hepatic epithelial stem-like cells were screened, and compounds 2, 6, 10, 18, and 32 showed potent hepatoprotective activities at concentrations of 1 x 10(-5) to 1 x 10(-4) M.

We designed nanofibrous hydrogels as 2-D and 3-D scaffolds for anchorage-dependent cells. The IKVAV-containing peptide amphiphile molecules spontaneously self-assembled into higher-order nanofiber hydrogels under cell-containing media. Neural progenitor cells (NPCs) were incubated in peptide-based hydrogels. Effects of self-assembling hydrogels on survival and neural differentiation of NPCs were observed. Peptide was synthesized using a solid-phase method. TEM study of the hydrogel revealed a network of nanofibers. Phase-contrast light micrographs showed that the described hydrogel had no observable cytotoxicity to NPCs. Additionally this hydrogel could induce cells to differentiate into neuron-like cells and glial-like cells. Moreover, the cells encapsulated within hydrogel had a higher neuronal differentiation rate than in the surface of the hydrogel. This self-assembled hydrogel might serve as nerve tissue-engineering scaffold.

No abstract

An IKVAV (Isoleucine-Lysine-Valine-Alanine-Valine)-containing peptide amphiphile molecule (IKVAV-PA) was implanted subcutaneouly into rat backbone in the middle. Angiogenesis induced by IKVAV-PA was evaluated in vivo. 200 µL of 10, 2, 1 and 0.5 wt% IKVAV-PA solution were added into DMEM/F 12 and self-assembled into nanofiber hydrogel. 1 mL of 1% IKVAV-PA (Experimental Group, EG) and 1 mL of 16.67% gelatin (Control Group, CG) were injected subcutaneously into rat backbone. The specimens were harvested two weeks after injection and examined immunohistochemically for VEGF(Vascular Endothelial Growth Factor). TEM observations of hydrogels revealed a network of nanofibers, and there was a significant positive correlation between IKVAV-PA concentration and nanofiber alignment. Light microscopy observation showed capillary vessel with complete walls formed in hydrogel, with erythrocytes noted inside the vessels in EG; capillary vessels or erythrocytes were not found within gelatin in CG. Immunohistochemical analysis revealed that there were VEGF-positive cells within hydrogel, which were not found in CG. Self-assembled hydrogel from IKVAV-PA was able to induce the angiogenesis in vivo.

Objective. To prepare a three-dimensional (3D) printing polylactic acid glycolic acid (PLGA) scaffold with bone morphogenetic protein-9 (BMP-9) and P-15 peptide hydrogel and evaluate its application in treating bone defects in rabbits. Methods. 3D printing PLGA scaffolds were formed and scanned by electron microscopy. Their X-ray diffraction (XRD), in vitro degradation, and compressive strength were characterized. BMP-9 and P-15 hydrogels were prepared. Flow cytometry was used to detect apoptosis, and an electron microscope was used to evaluate cell adhesion to scaffolds. Alkaline phosphatase (ALP), type 1 collagen (Col-I), osteocalcin (OCN), runt-related transcription factor 2 (RUNX2), and osterix (SP7) were detected by western blotting. MicroCT was used to detect new bone formation, and bone tissue-related protein expressions were determined in the rabbit model with bone defects. Results. The 3D printing scaffolds were cylindrical, and the inner diameter of the scaffolds was about 1 mm. The bread peak with wide distribution showed that the 3D printing only involved a physical change, which did not change the properties of the materials. The degradation rate of scaffolds was 9.38%, which met the requirements of properties of biological scaffolds. The water absorption of the support was about 9.09%, and the compressive strength was 15.83 N/mm2. In the coculture of bone marrow mesenchymal stem cells (BMSCs) with scaffolds, the 2% polypeptide hydrogel showed the most obvious activity in promoting the differentiation of BMSCs. Flow cytometry showed that the 0% and 2% groups did not cause obvious apoptosis compared with the control group. Scaffolds with 2% and 4% polypeptide promoted the expression of ALP, COL-1, OCN, RUNX2, and Sp7 in BMSCs. In vivo experiments showed that the expression of ALP, COL-1, OCN, RUNX2, and Sp7 protein in the 2% polypeptide scaffold group increased significantly compared with the model group. MicroCT detection demonstrated that the 2% polypeptide scaffold had good bone repair ability. Conclusion. The PLGA scaffolds combined with BMP-9 and P-15 peptide hydrogels had good biological and mechanical properties and could repair bone defects in rabbits.